EQS Newswire

The newsfeed available here is provided by our content partner EQS Group. This is one of the most important and widest-reaching press services in the D-A-CH region, providing news, press releases and multimedia content to the media, journalists and the public.
The NewsWire Hub ("X-Billboard") currently comprises four of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and provide a complementary range of information, more than three quarters of the official news sources on which editors worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
System-State: Number of processed items 49.082 Notifications successully processed since Inception
Der EQS-Newsfeed ist eine wichtige Nachrichtenquelle, die über das X-Billboard abgerufen werden kann. Sie ist Teil des Newswire-Hub, der für Börsianer wichtige internationalen Nachrichtenquellen an einem zentralen Ort bündelt. Wer sich schnell einen Überblick verschaffen will, kann sich bequem durch die Headlines scrollen. Wer sich detailliert mit den Nachrichten auseinandersetzen möchte, kann über die Detailansichten der Info-Cards direkt auf die jeweilige Nachricht und weitere Analysewerkzeuge zugreifen.
NEWS
EXPLORER
DE000A0LD6E6
State: 03.08.2023 | 6PM
Do you already know our new terminal view? Click here.
FIGI: BBG000PLZQH1
GXI

GERRESHEIMER AG
GICS: 35203010 · Sector: Basic materials · Sub-Sector: -
NAME
GERRESHEIMER AG
ISIN
DE000A0LD6E6
TICKER
GXI
MIC
XETR
REUTERS
GXIG.DE
BLOOMBERG
GXI GR
Thu, 16.12.2021       Gerresheimer

DGAP-Media / 16.12.2021 / 10:01 Gerresheimer enters into agreement with major American biotech to develop an innovative pump for rare diseases Important agreement with significant sales and revenue potential Development of a new pump to deliver a leading rare disease drug, using proven pump technology from Gerresheimer Sensile pump by G...
Tue, 23.11.2021       Gerresheimer

DGAP-Media / 23.11.2021 / 15:01 Gerresheimer successfully issues promissory loan - transaction again significantly oversubscribed Duesseldorf, November 23, 2021 - Gerresheimer AG has reached another milestone in the realization of its financing strategy by successfully issuing a new promissory loan. The total volume amounts to EUR 150 m, wi...
Mon, 08.11.2021       Gerresheimer

First own Gerresheimer Autoinjector - Gerresheimer and Midas Pharma announce strategic partnership Gerresheimer's first own IP autoinjector suitable for both small and large molecules enhances broad portfolio of solutions, medical devices and pharmaceutical primary packaging First joint project of Gerresheimer and Midas Pharma: Development and ma...
Tue, 12.10.2021       Gerresheimer

Core business revenue shows third-quarter organic growth of 9.8 % Strategic positioning as innovative provider of biotech, pharma and beauty solutions delivers results Adjusted EBITDA margin in core business organically at 20.9 % in third quarter Third-quarter adjusted earnings per share rise organically by 5.2 % Guidance confirmed for the fi...
Thu, 09.09.2021       Gerresheimer

Continuity on the Management Board: Gerresheimer extends contract with CFO Dr. Bernd Metzner ahead of schedule by a further five years Duesseldorf, September 9, 2021 - At its most recent meeting, the Supervisory Board of Gerresheimer AG prematurely extended the contract of Chief Financial Officer Dr. Bernd Metzner (50) by a further five years unt...
Tue, 13.07.2021       Gerresheimer

Gerresheimer accelerates revenue growth Organic Group revenue growth of 7.5 %, and 7.1 % in core business Solutions for biotech drugs and high-value solutions continue to drive revenues increase Organic adjusted EBITDA margin at 22.8 % in core business Adjusted earnings per share up organically by 19.1 % to EUR 1.28 Guidance confirmed for th...
Thu, 08.04.2021       Gerresheimer

Gerresheimer with positive start to the financial year 2021 - Organic revenue growth of 3.1 % in core business - Strong development in High Value Solutions: Focus on Biological Solutions pays off - Adjusted EBITDA increases organically by 7.0 % in core business - Adjusted earnings per share rise organically by 29.3 % to EUR 0.57 - Guidance co...
Tue, 13.10.2020       Gerresheimer

Gerresheimer on track for strong second half-year - Third quarter on schedule - Group revenues EUR 349m; 2.1% organic revenue growth in core business - Adjusted EBITDA increases by 4.1% to EUR 75m - Significant improvement in free cash flow to EUR 38m - Strong fourth quarter 2020 expected - Guidance for 2020 confirmed Duesseldorf, October...
Thu, 08.10.2020       Gerresheimer

Gerresheimer signs agreement for EUR 325m promissory loan Duesseldorf, October 08, 2020-Gerresheimer AG has signed a promissory loan agreement for a total of EUR 325m. The transaction with an initial issue amount of EUR 150m was substantially oversubscribed. Consequently, the total amount was increased to EUR 325m. The promissory loan comprises ...
Consequat mollit laboris sit voluptate duis duis mollit irure labore eu excepteur sit. Laboris cupidatat ullamco duis pariatur consequat culpa consectetur ex deserunt irure aute. Occaecat voluptate quis reprehenderit commodo minim aliquip sunt sint mollit. Magna enim ullamco amet ipsum cillum quis ipsum consectetur Lorem nostrud esse nisi. Nisi ut officia culpa ad id magna est aliqua consectetur est.